Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study

References

• VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• Montes de OcaMLópez VarelaMVLaucho-ContrerasMEClassification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD)Arch Bronconeumol20175339810627956034
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSpanish COPD guidelines (GesEPOC) 2017Pharmacological treatment of stable chronic obstructive pulmonary diseaseArch Bronconeumol201753632433528477954
   PubMed Web of Science ®Google Scholar
• PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
   PubMed Web of Science ®Google Scholar
• MakeBDutroMPPaulose-RamRMartonJPMapelDWUnder-treatment of COPD: a retrospective analysis of US managed care and Medicare patientsInt J Chron Obstruct Pulmon Dis201271922315517
   PubMed Web of Science ®Google Scholar
• BarrechegurenMMonteagudoMFerrerJTreatment patterns in COPD patients newly diagnosed in primary care. A population-based studyRespir Med2016111475326758585
   PubMed Web of Science ®Google Scholar
• MenezesAMPerez-PadillaRJardimJRChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554
   PubMed Web of Science ®Google Scholar
• Lopez VarelaMVMuiñoAPérez PadillaRTreatment of chronic obstructive pulmonary disease in 5 Latin American cities: the PLATINO studyArch Bronconeumol2008442586418361870
   PubMed Web of Science ®Google Scholar
• Montes de OcaMLopez VarelaMVJardimJStirvulovRSurmontFBronchodilator treatment for COPD in primary care of four Latin America countries: the multinational, cross-sectional, non-interventional PUMA studyPulmon Pharmacol Ther2016381016
   PubMed Web of Science ®Google Scholar
• JardimJRStirbulovRMorenoDZabertGLopez-VarelaMVMontes de OcaMRespiratory medication use in primary care among COPD subjects in four Latin American countriesInt J Tuberc Lung Dis201721445846528284262
   PubMed Web of Science ®Google Scholar
• Montes de OcaMMenezesAWehrmeisterFCAdherence to inhaled therapies of COPD patients from seven Latin American countries: the LASSYC studyPLoS One201712e018677729140978
   PubMed Web of Science ®Google Scholar
• MiravitllesMMenezesALópez VarelaMVPrevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: the LASSYC observational studyRespir Med20181341626929413510
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• PlazaVFernandez-RodriguezCMeleroCValidation of the “Test of the Adherence to Inhalers” (TAI) for asthma and COPD patientsJ Aerosol Med Pulm Drug Deliv201629214215226230150
   PubMed Web of Science ®Google Scholar
• SimeoneJCLuthraRKailaSInitiation of triple therapy maintenance treatment among patients with COPD in the USInt J Chron Obstruct Pulmon Dis201612738328053518
   PubMed Web of Science ®Google Scholar
• BurgelPRDesléeGJebrakGReal-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?Eur Respir J20144341201120324176996
   PubMed Web of Science ®Google Scholar
• BrusselleGPriceDGruffydd-JonesKThe inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UKInt J Chron Obstruct Pulmon Dis2015102207221726527869
   PubMed Web of Science ®Google Scholar
• WhitePThorntonHPinnockHGeorgopoulouSBoothHPOvertreatment of COPD with inhaled corticosteroids – implications for safety and costs: cross-sectional observational studyPLoS One2013810e7522124194824
   PubMed Web of Science ®Google Scholar
• FranssenFMSpruitMAWoutersEFDeterminants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011649350122069360
   PubMed Web of Science ®Google Scholar
• SenEGucluSZKibarIAdherence to GOLD guideline treatment recommendations among pulmonologists in TurkeyInt J Chron Obstruct Pulmon Dis2015102657266326715844
   PubMed Web of Science ®Google Scholar
• TuranOEmreJCDenizSBaysakATuranPAMiriciAAdherence to current COPD guidelines in TurkeyExpert Opin Pharmacother201617215315826629809
   PubMed Web of Science ®Google Scholar
• Montes de OcaMLópez VarelaMVAcuñaAALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answersArch Bronconeumol201551840341625596991
   PubMed Web of Science ®Google Scholar
• AscheCVLeaderSPlauschinatCAdherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroidsInt J Chron Obstruct Pulmon Dis2012720120922500120
   PubMed Web of Science ®Google Scholar
• BourbeauJSebaldtRJDayAPractice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE studyCan Respir J2008151131918292848
   PubMed Web of Science ®Google Scholar
• CorradoARossiAHow far is real life from COPD therapy guidelines? An Italian observational studyRespir Med2012106798999722483189
   PubMed Web of Science ®Google Scholar
• SinDDMiravitllesMManninoDMWhat is asthma–COPD overlap syndrome (ACOS)? Towards a consensus definition from a roundtable discussionEur Respir J201648366467327338195
   PubMed Web of Science ®Google Scholar
• PlazaVÁlvarezFCalleMConsensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)Arch Bronconeumol201753844344928495077
   PubMed Web of Science ®Google Scholar
• CecereLMSlatoreCGUmanJEAdherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD)COPD20129325125822497533
   PubMedGoogle Scholar
• IngebrigtsenTSMarottJLNordestgaardBGLow use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general populationJ Gen Intern Med2015301515925245885
   PubMed Web of Science ®Google Scholar
• HuetschJCUmanJEUdrisEMAuDHPredictors of adherence to inhaled medications among veterans with COPDJ Gen Intern Med201227111506151222782274
   PubMed Web of Science ®Google Scholar
• Penning-van BeestFvan Herk-SukelMGaleRLammersJWHeringsRThree-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysisRespir Med2011105225926520705441
   PubMed Web of Science ®Google Scholar
• Breekveldt-PostmaNSKoerselmanJErkensJALammersJWHeringsRMEnhanced persistence with tiotropium compared with other respiratory drugs in COPDRespir Med200710171398140517368011
   PubMed Web of Science ®Google Scholar
• MonteagudoMRosetMRodriguez-BlancoTMuñozLMiravitllesMCharacteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based studyInt J Chron Obstruct Pulmon Dis2017121145115228442901
   PubMed Web of Science ®Google Scholar
• CheyneLIrvin-SellersMJWhiteJTiotropium versus ipratropium bromide for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20159CD009552
   Google Scholar
• AppletonSPoolePSmithBVealeALassersonTJChanMMLong-acting beta2-agonists for poorly reversible chronic obstructive pulmonary diseaseCochrane Database Syst Rev20063CD001104
   Google Scholar